comparison of rosuvastatin alone versus ezetimib plus standard statin on lipid-lowering effects in patients with dyslipidemia
Not Applicable
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000002802
- Lead Sponsor
- Department of Medicine II, Hokkaido University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who has been treated by any strong statins (rosvastatin, atrovastatin, and pitavastatin) or ezetimib. 2. Patients who are suffered from severe liver, kidney, or heart diseases. 3. Patients who are pregnant, lactating, or could be pregnant 4. Patients with the history of allergy for study drugs. 5. Patients treated with cyclosporin. 6. Patients were deemed inappropriate for this study as the doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method